nodes	percent_of_prediction	percent_of_DWPC	metapath
Enzalutamide—CYP2C19—Esomeprazole—Barrett's esophagus	0.18	0.224	CbGbCtD
Enzalutamide—CYP2C8—Omeprazole—Barrett's esophagus	0.126	0.157	CbGbCtD
Enzalutamide—CYP2C19—Omeprazole—Barrett's esophagus	0.106	0.132	CbGbCtD
Enzalutamide—CYP2C9—Omeprazole—Barrett's esophagus	0.0881	0.11	CbGbCtD
Enzalutamide—CYP3A4—Esomeprazole—Barrett's esophagus	0.087	0.108	CbGbCtD
Enzalutamide—ABCB1—Omeprazole—Barrett's esophagus	0.0855	0.106	CbGbCtD
Enzalutamide—CYP2D6—Omeprazole—Barrett's esophagus	0.0806	0.1	CbGbCtD
Enzalutamide—CYP3A4—Omeprazole—Barrett's esophagus	0.0513	0.0637	CbGbCtD
Enzalutamide—Fracture—Omeprazole—Barrett's esophagus	0.00635	0.0385	CcSEcCtD
Enzalutamide—Multiple fractures—Esomeprazole—Barrett's esophagus	0.00635	0.0385	CcSEcCtD
Enzalutamide—Fracture—Esomeprazole—Barrett's esophagus	0.00635	0.0385	CcSEcCtD
Enzalutamide—Multiple fractures—Omeprazole—Barrett's esophagus	0.00635	0.0385	CcSEcCtD
Enzalutamide—Injury—Omeprazole—Barrett's esophagus	0.00291	0.0177	CcSEcCtD
Enzalutamide—Injury—Esomeprazole—Barrett's esophagus	0.00291	0.0177	CcSEcCtD
Enzalutamide—Hot flush—Esomeprazole—Barrett's esophagus	0.00286	0.0174	CcSEcCtD
Enzalutamide—Hot flush—Omeprazole—Barrett's esophagus	0.00286	0.0174	CcSEcCtD
Enzalutamide—Menopausal symptoms—Omeprazole—Barrett's esophagus	0.00284	0.0172	CcSEcCtD
Enzalutamide—Menopausal symptoms—Esomeprazole—Barrett's esophagus	0.00284	0.0172	CcSEcCtD
Enzalutamide—Dry skin—Esomeprazole—Barrett's esophagus	0.00246	0.0149	CcSEcCtD
Enzalutamide—Dry skin—Omeprazole—Barrett's esophagus	0.00246	0.0149	CcSEcCtD
Enzalutamide—Muscular weakness—Esomeprazole—Barrett's esophagus	0.00236	0.0143	CcSEcCtD
Enzalutamide—Muscular weakness—Omeprazole—Barrett's esophagus	0.00236	0.0143	CcSEcCtD
Enzalutamide—Neutropenia—Omeprazole—Barrett's esophagus	0.00216	0.0131	CcSEcCtD
Enzalutamide—Neutropenia—Esomeprazole—Barrett's esophagus	0.00216	0.0131	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.00215	0.013	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.00215	0.013	CcSEcCtD
Enzalutamide—Pollakiuria—Omeprazole—Barrett's esophagus	0.00214	0.013	CcSEcCtD
Enzalutamide—Pollakiuria—Esomeprazole—Barrett's esophagus	0.00214	0.013	CcSEcCtD
Enzalutamide—Infestation—Esomeprazole—Barrett's esophagus	0.00206	0.0125	CcSEcCtD
Enzalutamide—Infestation NOS—Omeprazole—Barrett's esophagus	0.00206	0.0125	CcSEcCtD
Enzalutamide—Infestation NOS—Esomeprazole—Barrett's esophagus	0.00206	0.0125	CcSEcCtD
Enzalutamide—Infestation—Omeprazole—Barrett's esophagus	0.00206	0.0125	CcSEcCtD
Enzalutamide—Haematuria—Omeprazole—Barrett's esophagus	0.00197	0.0119	CcSEcCtD
Enzalutamide—Haematuria—Esomeprazole—Barrett's esophagus	0.00197	0.0119	CcSEcCtD
Enzalutamide—Epistaxis—Omeprazole—Barrett's esophagus	0.00195	0.0118	CcSEcCtD
Enzalutamide—Epistaxis—Esomeprazole—Barrett's esophagus	0.00195	0.0118	CcSEcCtD
Enzalutamide—Sinusitis—Omeprazole—Barrett's esophagus	0.00194	0.0117	CcSEcCtD
Enzalutamide—Sinusitis—Esomeprazole—Barrett's esophagus	0.00194	0.0117	CcSEcCtD
Enzalutamide—Rhinitis—Esomeprazole—Barrett's esophagus	0.00186	0.0113	CcSEcCtD
Enzalutamide—Rhinitis—Omeprazole—Barrett's esophagus	0.00186	0.0113	CcSEcCtD
Enzalutamide—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.00184	0.0112	CcSEcCtD
Enzalutamide—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.00184	0.0112	CcSEcCtD
Enzalutamide—Pharyngitis—Omeprazole—Barrett's esophagus	0.00184	0.0112	CcSEcCtD
Enzalutamide—Pharyngitis—Esomeprazole—Barrett's esophagus	0.00184	0.0112	CcSEcCtD
Enzalutamide—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.00183	0.0111	CcSEcCtD
Enzalutamide—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.00183	0.0111	CcSEcCtD
Enzalutamide—Oedema peripheral—Omeprazole—Barrett's esophagus	0.00183	0.0111	CcSEcCtD
Enzalutamide—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.00183	0.0111	CcSEcCtD
Enzalutamide—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.00182	0.011	CcSEcCtD
Enzalutamide—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.00182	0.011	CcSEcCtD
Enzalutamide—Urethral disorder—Esomeprazole—Barrett's esophagus	0.00182	0.011	CcSEcCtD
Enzalutamide—Urethral disorder—Omeprazole—Barrett's esophagus	0.00182	0.011	CcSEcCtD
Enzalutamide—ALB—FOXA2 and FOXA3 transcription factor networks—FOXF1—Barrett's esophagus	0.00162	0.0537	CbGpPWpGaD
Enzalutamide—Mental disorder—Esomeprazole—Barrett's esophagus	0.00162	0.00985	CcSEcCtD
Enzalutamide—Mental disorder—Omeprazole—Barrett's esophagus	0.00162	0.00985	CcSEcCtD
Enzalutamide—Back pain—Omeprazole—Barrett's esophagus	0.00156	0.00946	CcSEcCtD
Enzalutamide—Back pain—Esomeprazole—Barrett's esophagus	0.00156	0.00946	CcSEcCtD
Enzalutamide—Vertigo—Omeprazole—Barrett's esophagus	0.00145	0.00879	CcSEcCtD
Enzalutamide—Vertigo—Esomeprazole—Barrett's esophagus	0.00145	0.00879	CcSEcCtD
Enzalutamide—Leukopenia—Omeprazole—Barrett's esophagus	0.00144	0.00876	CcSEcCtD
Enzalutamide—Leukopenia—Esomeprazole—Barrett's esophagus	0.00144	0.00876	CcSEcCtD
Enzalutamide—Hypertension—Omeprazole—Barrett's esophagus	0.00139	0.00845	CcSEcCtD
Enzalutamide—Hypertension—Esomeprazole—Barrett's esophagus	0.00139	0.00845	CcSEcCtD
Enzalutamide—Arthralgia—Omeprazole—Barrett's esophagus	0.00137	0.00833	CcSEcCtD
Enzalutamide—Arthralgia—Esomeprazole—Barrett's esophagus	0.00137	0.00833	CcSEcCtD
Enzalutamide—Anxiety—Omeprazole—Barrett's esophagus	0.00137	0.0083	CcSEcCtD
Enzalutamide—Anxiety—Esomeprazole—Barrett's esophagus	0.00137	0.0083	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00136	0.00827	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00136	0.00827	CcSEcCtD
Enzalutamide—AR—Nuclear Receptors—NR1I2—Barrett's esophagus	0.00133	0.0439	CbGpPWpGaD
Enzalutamide—Infection—Omeprazole—Barrett's esophagus	0.00131	0.00793	CcSEcCtD
Enzalutamide—Infection—Esomeprazole—Barrett's esophagus	0.00131	0.00793	CcSEcCtD
Enzalutamide—Nervous system disorder—Omeprazole—Barrett's esophagus	0.00129	0.00783	CcSEcCtD
Enzalutamide—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.00129	0.00783	CcSEcCtD
Enzalutamide—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.00129	0.00782	CcSEcCtD
Enzalutamide—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.00129	0.00782	CcSEcCtD
Enzalutamide—Skin disorder—Esomeprazole—Barrett's esophagus	0.00128	0.00776	CcSEcCtD
Enzalutamide—Skin disorder—Omeprazole—Barrett's esophagus	0.00128	0.00776	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.0012	0.00727	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.0012	0.00727	CcSEcCtD
Enzalutamide—Insomnia—Omeprazole—Barrett's esophagus	0.00119	0.00722	CcSEcCtD
Enzalutamide—Insomnia—Esomeprazole—Barrett's esophagus	0.00119	0.00722	CcSEcCtD
Enzalutamide—Paraesthesia—Omeprazole—Barrett's esophagus	0.00118	0.00717	CcSEcCtD
Enzalutamide—Paraesthesia—Esomeprazole—Barrett's esophagus	0.00118	0.00717	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.00114	0.00689	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.00114	0.00689	CcSEcCtD
Enzalutamide—Fatigue—Esomeprazole—Barrett's esophagus	0.00113	0.00688	CcSEcCtD
Enzalutamide—Fatigue—Omeprazole—Barrett's esophagus	0.00113	0.00688	CcSEcCtD
Enzalutamide—AR—Nuclear Receptor transcription pathway—NR1I2—Barrett's esophagus	0.00105	0.0347	CbGpPWpGaD
Enzalutamide—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00103	0.0341	CbGpPWpGaD
Enzalutamide—Asthenia—Omeprazole—Barrett's esophagus	0.000944	0.00573	CcSEcCtD
Enzalutamide—Asthenia—Esomeprazole—Barrett's esophagus	0.000944	0.00573	CcSEcCtD
Enzalutamide—Pruritus—Esomeprazole—Barrett's esophagus	0.000931	0.00565	CcSEcCtD
Enzalutamide—Pruritus—Omeprazole—Barrett's esophagus	0.000931	0.00565	CcSEcCtD
Enzalutamide—Diarrhoea—Omeprazole—Barrett's esophagus	0.000901	0.00546	CcSEcCtD
Enzalutamide—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000901	0.00546	CcSEcCtD
Enzalutamide—Dizziness—Esomeprazole—Barrett's esophagus	0.000871	0.00528	CcSEcCtD
Enzalutamide—Dizziness—Omeprazole—Barrett's esophagus	0.000871	0.00528	CcSEcCtD
Enzalutamide—Headache—Esomeprazole—Barrett's esophagus	0.000825	0.005	CcSEcCtD
Enzalutamide—Headache—Omeprazole—Barrett's esophagus	0.000825	0.005	CcSEcCtD
Enzalutamide—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000803	0.0265	CbGpPWpGaD
Enzalutamide—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000803	0.0265	CbGpPWpGaD
Enzalutamide—CYP2C8—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000659	0.0218	CbGpPWpGaD
Enzalutamide—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000635	0.021	CbGpPWpGaD
Enzalutamide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000592	0.0196	CbGpPWpGaD
Enzalutamide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000592	0.0196	CbGpPWpGaD
Enzalutamide—CYP2C19—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000588	0.0194	CbGpPWpGaD
Enzalutamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000553	0.0183	CbGpPWpGaD
Enzalutamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000553	0.0183	CbGpPWpGaD
Enzalutamide—CYP3A5—Irinotecan Pathway—APC—Barrett's esophagus	0.000544	0.018	CbGpPWpGaD
Enzalutamide—CYP2C9—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000536	0.0177	CbGpPWpGaD
Enzalutamide—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00051	0.0168	CbGpPWpGaD
Enzalutamide—CYP2B6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000503	0.0166	CbGpPWpGaD
Enzalutamide—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000498	0.0165	CbGpPWpGaD
Enzalutamide—CYP3A5—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000492	0.0162	CbGpPWpGaD
Enzalutamide—AR—Nuclear Receptors—PPARG—Barrett's esophagus	0.000437	0.0145	CbGpPWpGaD
Enzalutamide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000431	0.0143	CbGpPWpGaD
Enzalutamide—CYP2C8—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000426	0.0141	CbGpPWpGaD
Enzalutamide—CYP2B6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000413	0.0137	CbGpPWpGaD
Enzalutamide—CYP3A5—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000404	0.0133	CbGpPWpGaD
Enzalutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000385	0.0127	CbGpPWpGaD
Enzalutamide—ABCB1—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.000381	0.0126	CbGpPWpGaD
Enzalutamide—CYP2C19—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00038	0.0126	CbGpPWpGaD
Enzalutamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000365	0.0121	CbGpPWpGaD
Enzalutamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000365	0.0121	CbGpPWpGaD
Enzalutamide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000354	0.0117	CbGpPWpGaD
Enzalutamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000351	0.0116	CbGpPWpGaD
Enzalutamide—CYP2C8—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00035	0.0116	CbGpPWpGaD
Enzalutamide—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00035	0.0116	CbGpPWpGaD
Enzalutamide—CYP2C9—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000346	0.0115	CbGpPWpGaD
Enzalutamide—AR—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.000346	0.0114	CbGpPWpGaD
Enzalutamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000312	0.0103	CbGpPWpGaD
Enzalutamide—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000287	0.00949	CbGpPWpGaD
Enzalutamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000285	0.00941	CbGpPWpGaD
Enzalutamide—AR—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.000277	0.00915	CbGpPWpGaD
Enzalutamide—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000264	0.00873	CbGpPWpGaD
Enzalutamide—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000253	0.00836	CbGpPWpGaD
Enzalutamide—AR—Coregulation of Androgen receptor activity—CDKN2A—Barrett's esophagus	0.000252	0.00833	CbGpPWpGaD
Enzalutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—Barrett's esophagus	0.00025	0.00826	CbGpPWpGaD
Enzalutamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000232	0.00765	CbGpPWpGaD
Enzalutamide—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000229	0.00755	CbGpPWpGaD
Enzalutamide—CYP2B6—Biological oxidations—CYP26A1—Barrett's esophagus	0.000219	0.00725	CbGpPWpGaD
Enzalutamide—CYP2B6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000216	0.00715	CbGpPWpGaD
Enzalutamide—CYP3A5—Biological oxidations—CYP26A1—Barrett's esophagus	0.000214	0.00709	CbGpPWpGaD
Enzalutamide—CYP3A5—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000212	0.00699	CbGpPWpGaD
Enzalutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—Barrett's esophagus	0.000203	0.0067	CbGpPWpGaD
Enzalutamide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000195	0.00644	CbGpPWpGaD
Enzalutamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000188	0.00621	CbGpPWpGaD
Enzalutamide—CYP2C8—Biological oxidations—CYP26A1—Barrett's esophagus	0.000186	0.00614	CbGpPWpGaD
Enzalutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—Barrett's esophagus	0.000184	0.00608	CbGpPWpGaD
Enzalutamide—CYP2C8—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000183	0.00606	CbGpPWpGaD
Enzalutamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000182	0.00602	CbGpPWpGaD
Enzalutamide—AR—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.000181	0.006	CbGpPWpGaD
Enzalutamide—AR—Androgen receptor signaling pathway—RELA—Barrett's esophagus	0.000179	0.00592	CbGpPWpGaD
Enzalutamide—CYP2C19—Biological oxidations—CYP26A1—Barrett's esophagus	0.000166	0.00548	CbGpPWpGaD
Enzalutamide—CYP2C19—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000164	0.00541	CbGpPWpGaD
Enzalutamide—ALB—Platelet degranulation—HGF—Barrett's esophagus	0.000156	0.00517	CbGpPWpGaD
Enzalutamide—CYP2D6—Biological oxidations—CYP26A1—Barrett's esophagus	0.000153	0.00504	CbGpPWpGaD
Enzalutamide—CYP2C9—Biological oxidations—CYP26A1—Barrett's esophagus	0.000151	0.005	CbGpPWpGaD
Enzalutamide—CYP2D6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.00015	0.00497	CbGpPWpGaD
Enzalutamide—CYP2C9—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000149	0.00493	CbGpPWpGaD
Enzalutamide—ALB—Response to elevated platelet cytosolic Ca2+—HGF—Barrett's esophagus	0.000149	0.00493	CbGpPWpGaD
Enzalutamide—ALB—Vitamin B12 Metabolism—RELA—Barrett's esophagus	0.00013	0.0043	CbGpPWpGaD
Enzalutamide—CYP2C8—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000129	0.00427	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000124	0.00412	CbGpPWpGaD
Enzalutamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.00012	0.00397	CbGpPWpGaD
Enzalutamide—CYP2C19—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000115	0.00381	CbGpPWpGaD
Enzalutamide—AR—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	0.000108	0.00356	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—RELA—Barrett's esophagus	0.000106	0.0035	CbGpPWpGaD
Enzalutamide—CYP2C9—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000105	0.00348	CbGpPWpGaD
Enzalutamide—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	9.97e-05	0.0033	CbGpPWpGaD
Enzalutamide—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	9.83e-05	0.00325	CbGpPWpGaD
Enzalutamide—ALB—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	9.57e-05	0.00316	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	9.45e-05	0.00312	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	9.41e-05	0.00311	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	9.36e-05	0.00309	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—NR1I2—Barrett's esophagus	8.73e-05	0.00289	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—RELA—Barrett's esophagus	8.41e-05	0.00278	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	8.4e-05	0.00278	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	8.17e-05	0.0027	CbGpPWpGaD
Enzalutamide—ALB—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	7.93e-05	0.00262	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	7.66e-05	0.00253	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	7.57e-05	0.0025	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	6.95e-05	0.0023	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	6.94e-05	0.00229	CbGpPWpGaD
Enzalutamide—AR—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	6.79e-05	0.00224	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—TP53—Barrett's esophagus	6.12e-05	0.00202	CbGpPWpGaD
Enzalutamide—AR—Generic Transcription Pathway—PPARG—Barrett's esophagus	5.97e-05	0.00197	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	5.63e-05	0.00186	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	5.07e-05	0.00168	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PTGES—Barrett's esophagus	4.95e-05	0.00164	CbGpPWpGaD
Enzalutamide—ALB—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	4.86e-05	0.00161	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PTGES—Barrett's esophagus	4.84e-05	0.0016	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	4.26e-05	0.00141	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PTGES—Barrett's esophagus	4.19e-05	0.00139	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PTGES—Barrett's esophagus	4.17e-05	0.00138	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	3.85e-05	0.00127	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CYP26A1—Barrett's esophagus	3.75e-05	0.00124	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PTGES—Barrett's esophagus	3.74e-05	0.00124	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CYP26A1—Barrett's esophagus	3.67e-05	0.00121	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PTGES—Barrett's esophagus	3.65e-05	0.00121	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—HGF—Barrett's esophagus	3.58e-05	0.00118	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PTGES—Barrett's esophagus	3.44e-05	0.00114	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PTGES—Barrett's esophagus	3.41e-05	0.00113	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CYP26A1—Barrett's esophagus	3.18e-05	0.00105	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CYP26A1—Barrett's esophagus	3.16e-05	0.00104	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—PPARG—Barrett's esophagus	2.87e-05	0.00095	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CYP26A1—Barrett's esophagus	2.84e-05	0.000937	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	2.77e-05	0.000915	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—SLC9A1—Barrett's esophagus	2.71e-05	0.000894	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—SLC9A1—Barrett's esophagus	2.64e-05	0.000874	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	2.61e-05	0.000862	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYP26A1—Barrett's esophagus	2.59e-05	0.000855	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.35e-05	0.000776	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.33e-05	0.000772	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	2.29e-05	0.000758	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—SLC9A1—Barrett's esophagus	2.29e-05	0.000757	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—SLC9A1—Barrett's esophagus	2.28e-05	0.000753	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PTGES—Barrett's esophagus	2.25e-05	0.000744	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.1e-05	0.000693	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—SLC9A1—Barrett's esophagus	2.04e-05	0.000676	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	2e-05	0.00066	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.91e-05	0.000632	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	1.88e-05	0.000622	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—SLC9A1—Barrett's esophagus	1.86e-05	0.000616	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.85e-05	0.00061	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.84e-05	0.000607	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	1.71e-05	0.000564	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.65e-05	0.000545	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.5e-05	0.000497	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PPARG—Barrett's esophagus	1.23e-05	0.000408	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	1.23e-05	0.000406	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PPARG—Barrett's esophagus	1.21e-05	0.000399	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—TP53—Barrett's esophagus	1.2e-05	0.000397	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PPARG—Barrett's esophagus	1.05e-05	0.000346	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PPARG—Barrett's esophagus	1.04e-05	0.000344	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PTGS2—Barrett's esophagus	9.71e-06	0.000321	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PTGS2—Barrett's esophagus	9.49e-06	0.000314	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PPARG—Barrett's esophagus	9.33e-06	0.000308	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PPARG—Barrett's esophagus	9.11e-06	0.000301	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PPARG—Barrett's esophagus	8.58e-06	0.000284	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PPARG—Barrett's esophagus	8.51e-06	0.000281	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PTGS2—Barrett's esophagus	8.22e-06	0.000272	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PTGS2—Barrett's esophagus	8.18e-06	0.00027	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PTGS2—Barrett's esophagus	7.34e-06	0.000243	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PTGS2—Barrett's esophagus	7.16e-06	0.000237	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	6.75e-06	0.000223	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PTGS2—Barrett's esophagus	6.69e-06	0.000221	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PPARG—Barrett's esophagus	5.61e-06	0.000185	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	4.41e-06	0.000146	CbGpPWpGaD
